KIMBERLY GORDON: Open Payments
NPI 1427590926 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,340 in 68 payments from 10 companies in 2025. Trend: 2023 $1,228 · 2024 $1,127 · 2025 $1,340
Food & beverage: $1,229Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $225 |
| Teva Pharmaceuticals USA, Inc. | 8 | $220 |
| ABBVIE INC. | 14 | $195 |
| Neurocrine BioSciences, Inc. | 9 | $161 |
| Vanda Pharmaceuticals Inc. | 6 | $120 |
| Alkermes, Inc. | 6 | $116 |
| Otsuka America Pharmaceutical, Inc. | 5 | $89 |
| Lundbeck LLC | 4 | $87 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| E.R. Squibb & Sons, L.L.C. | 2 | $50 |
Products named: CAPLYTA, VRAYLAR, INGREZZA, REXULTI, FANAPT, ARISTADA, AUSTEDO XR, Auvelity.
Industry payments across TX — which companies pay providers there.
